SJ medical
1 / 5
| Product name | Dasatinib monohydrate |
| CAS NO | 863127-77-9 |
| Melting point | 203-213ºC |
| Boiling point | 417.3±45.0ºC |
| Density | 1.315 |
Dasatinib Monohydrate is an oral Bcr-Abl tyrosine kinase inhibitor (inhibits the "Philadelphia chromosome") and Src family tyrosine kinase inhibitor approved for first line use in patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It is being evaluated for use in numerous other cancers, including advanced prostate cancer.
Our Dasatinib Monohydrate maintains a high purity level of over 99%, ensuring optimal efficacy for research and pharmaceutical applications.
Yes, OEM services are available to meet specific requirements for packaging and formulation.
The standard transport package is a secure Foil Bag to protect the powder from moisture and light during shipping.
Yes, samples are available for quality testing and verification purposes.
The product is compliant with GMP, HSE, ISO 9001, USP, and BP standards.
We have a strong supply chain capable of producing up to 10,000 Kgs per month.
